Skip to main content
. 2017 Mar 1;22(4):293–300. doi: 10.1111/nep.12891

Figure 4.

Figure 4

Achievement rates of target serum phosphorus concentration (per protocol set). The achievement rates of target serum phosphorus concentration (1.13–1.94 mmol/L) at the end of treatment were 82.0% and 67.4% in the PA21 (sucroferric oxyhydroxide) and sevelamer groups, respectively. The rates were >80% in the PA21 group after Week 6. Meanwhile, the rates were significantly higher in the PA21 group than in the sevelamer group after Week 8. EP, endpoint. *P < 0.05.